HIT Consultant May 3, 2024
What You Should Know:
– BioPhy, an AI drug development company, and Every Cure, a non-profit dedicated to unlocking the potential of existing drugs for new uses, today announced a strategic partnership to revolutionize drug repurposing through artificial intelligence (AI).
– The partnership follows Every Cure’s recent funding from the Advanced Research Projects Agency for Health (ARPA-H). A successful pilot using AI led to the identification of potential treatments for diseases like sickle cell disease, ALS, and autism spectrum disorder.
Unlocking Hidden Cures on the Pharmacy Shelf
Every Cure aims to identify new uses for existing medications, potentially saving patients from suffering while effective treatments remain undiscovered. This partnership will leverage BioPhy’s BioLogicAI platform to:
- Identify Promising Drug-Disease Matches:...
Today's Sponsors
Today's Sponsor